ArticleAdvanced biology2026
Patterning of Multilayer Biointerfaces Driven by Microbubble Lithography Toward Optical Biochips.
Article in Advanced biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The precise and non-invasive integration of biological molecules into engineered surfaces remains a critical challenge in the development of advanced biointerfaces for biophotonics applications. Traditional fabrication techniques often rely on harsh chemical processes or photolithographic steps that risk compromising biomolecular function and lack microscale spatial selectivity. In this context, Microbubble Lithography (MBL) has established itself as an optical tweezers driven microbubble-based mask-free route toward patterning of biointerfaces in order to fabricate three-layer biointerfaces entirely in situ. This work reinforces this technology further and provides important advances in the form of quantitative understanding of the controlled patterning of fluorescent reporters on a heterostructured interface enhanced by an absorbing substrate and a cross-linker to improve interfacial stability and signal-to-noise ratios. We address important questions regarding adherence, reporter and cross-linker concentrations, while also studying the science behind the formation of such heterostructures. Thus, we explain the observed twin-peak, edge-dominated fluorescence via a phenomenological model using central thermophoretic depletion and peripheral enrichment at the three-phase contact line (TPCL), and a 3D fluorescence surface visualizing peripheral enrichment. Together, these results establish MBL as a mask-free, chemically gentle, and highly controllable route to construct an optical biochip platform to fabricate biomolecular architectures for biophotonics and biosensing applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.